Sihuan bought China rights. https://markets.businessinsider.com/news/stocks/sihuan-pharmaceutical-announces-acquisition-of-all-interests-and-intellectual-property-rights-of-plazomicin-a-new-generation-of-aminoglycoside-antibiotics-in-the-greater-china-region-1028922754